Stock Track | Adaptive Biotechnologies Soars 16.11% After-Hours on Strong Q1 Earnings Beat

Stock Track05-06

Shares of Adaptive Biotechnologies Corp surged 16.11% in after-hours trading on Tuesday following the release of the company's first-quarter 2026 financial results.

The significant price increase was driven by the company reporting better-than-expected quarterly performance. Adaptive Biotechnologies posted Q1 revenue of $70.874 million, which exceeded analyst estimates of $60.9 million by approximately 16.5% and represented a 35% increase year-over-year. The company also reported a quarterly loss per share of $0.13, beating the consensus estimate of a $0.17 loss by 23.5%.

Further bolstering investor sentiment, the company's net loss narrowed to $20 million compared to the same period last year, while adjusted EBITDA of -$2.5 million also came in significantly better than the -$6.55 million estimate. The strong results demonstrate improved operational performance and financial health for the biotechnology firm.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1173247451?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-06 04:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1173247451","market":"us","top_or_hot":-1,"title":"Stock Track | Adaptive Biotechnologies Soars 16.11% After-Hours on Strong Q1 Earnings Beat","media":"Stock Track","content":"<p>Shares of Adaptive Biotechnologies Corp surged 16.11% in after-hours trading on Tuesday following the release of the company's first-quarter 2026 financial results.</p><p>The significant price increase was driven by the company reporting better-than-expected quarterly performance. Adaptive Biotechnologies posted Q1 revenue of $70.874 million, which exceeded analyst estimates of $60.9 million by approximately 16.5% and represented a 35% increase year-over-year. The company also reported a quarterly loss per share of $0.13, beating the consensus estimate of a $0.17 loss by 23.5%.</p><p>Further bolstering investor sentiment, the company's net loss narrowed to $20 million compared to the same period last year, while adjusted EBITDA of -$2.5 million also came in significantly better than the -$6.55 million estimate. The strong results demonstrate improved operational performance and financial health for the biotechnology firm.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Adaptive Biotechnologies Soars 16.11% After-Hours on Strong Q1 Earnings Beat</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Adaptive Biotechnologies Soars 16.11% After-Hours on Strong Q1 Earnings Beat\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-06 04:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Adaptive Biotechnologies Corp surged 16.11% in after-hours trading on Tuesday following the release of the company's first-quarter 2026 financial results.</p><p>The significant price increase was driven by the company reporting better-than-expected quarterly performance. Adaptive Biotechnologies posted Q1 revenue of $70.874 million, which exceeded analyst estimates of $60.9 million by approximately 16.5% and represented a 35% increase year-over-year. The company also reported a quarterly loss per share of $0.13, beating the consensus estimate of a $0.17 loss by 23.5%.</p><p>Further bolstering investor sentiment, the company's net loss narrowed to $20 million compared to the same period last year, while adjusted EBITDA of -$2.5 million also came in significantly better than the -$6.55 million estimate. The strong results demonstrate improved operational performance and financial health for the biotechnology firm.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ADPT","symbol_name":"Adaptive Biotechnologies Corp","start_time":0,"source_url":"","article_id":"1173247451","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1173247451","pubTimestamp":1778014147,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Adaptive Biotechnologies Corp surged 16.11% in after-hours trading on Tuesday following the release of the company's first-quarter 2026 financial results.The significant price increase was...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ADPT":"Adaptive Biotechnologies Corp"},"translate_title":"个股追踪|Adaptive Biotechnologies盘后飙升16.11%，因Q1盈利强劲","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ADPT":1},"content_text":"Shares of Adaptive Biotechnologies Corp surged 16.11% in after-hours trading on Tuesday following the release of the company's first-quarter 2026 financial results.The significant price increase was driven by the company reporting better-than-expected quarterly performance. Adaptive Biotechnologies posted Q1 revenue of $70.874 million, which exceeded analyst estimates of $60.9 million by approximately 16.5% and represented a 35% increase year-over-year. The company also reported a quarterly loss per share of $0.13, beating the consensus estimate of a $0.17 loss by 23.5%.Further bolstering investor sentiment, the company's net loss narrowed to $20 million compared to the same period last year, while adjusted EBITDA of -$2.5 million also came in significantly better than the -$6.55 million estimate. The strong results demonstrate improved operational performance and financial health for the biotechnology firm.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1173247451","isCrawlerRequest":true}